MedPath

湖南天济草堂制药股份有限公司

Ownership
-
Established
1992-11-20
Employees
-
Market Cap
-
Website
www.bjyy.net.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

NMPA:24

Drug Approvals

Oseltamivir Phosphate Granules

Product Name
磷酸奥司他韦颗粒
Approval Number
国药准字H20249791
Approval Date
Dec 25, 2024
NMPA

妇科十味胶囊

Approval Number
国药准字Z20090011
Approval Date
May 12, 2023
NMPA

清热散结胶囊

Approval Number
国药准字Z20133038
Approval Date
Apr 7, 2023
NMPA

消癌平片

Approval Number
国药准字Z20083317
Approval Date
Nov 28, 2022
NMPA

Fufang Shiwei Capsules

Product Name
复方石韦胶囊
Approval Number
国药准字Z20123064
Approval Date
Dec 15, 2021
NMPA

复方石淋通胶囊

Approval Number
国药准字Z20173015
Approval Date
Dec 15, 2021
NMPA

护肝宁胶囊

Approval Number
国药准字Z20123004
Approval Date
Sep 15, 2021
NMPA

舒筋活血胶囊

Approval Number
国药准字Z20123005
Approval Date
Sep 15, 2021
NMPA

障眼明胶囊

Approval Number
国药准字Z20123006
Approval Date
Sep 15, 2021
NMPA

女宝胶囊

Approval Number
国药准字Z43020169
Approval Date
Aug 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.